201 related articles for article (PubMed ID: 1285067)
1. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.
Kemp PA; Spragg JH; Brown JC; Morgan BP; Gunn CA; Taylor PW
J Clin Lab Immunol; 1992; 37(4):147-62. PubMed ID: 1285067
[TBL] [Abstract][Full Text] [Related]
2. Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy.
Sanders ME; Kopicky JA; Wigley FM; Shin ML; Frank MM; Joiner KA
J Rheumatol; 1986 Dec; 13(6):1028-34. PubMed ID: 3550070
[TBL] [Abstract][Full Text] [Related]
3. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
5. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
6. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma.
Corvetta A; Pomponio G; Rinaldi N; Luchetti MM; Di Loreto C; Stramazzotti D
Clin Exp Rheumatol; 1992; 10(5):433-8. PubMed ID: 1458695
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis.
de Graeff-Meeder ER; Voorhorst M; van Eden W; Schuurman HJ; Huber J; Barkley D; Maini RN; Kuis W; Rijkers GT; Zegers BJ
Am J Pathol; 1990 Nov; 137(5):1013-7. PubMed ID: 1700613
[TBL] [Abstract][Full Text] [Related]
9. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis.
van Holten J; Smeets TJ; Blankert P; Tak PP
Ann Rheum Dis; 2005 Dec; 64(12):1780-2. PubMed ID: 15878901
[TBL] [Abstract][Full Text] [Related]
10. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.
Konttinen YT; Ceponis A; Meri S; Vuorikoski A; Kortekangas P; Sorsa T; Sukura A; Santavirta S
Ann Rheum Dis; 1996 Dec; 55(12):888-94. PubMed ID: 9014582
[TBL] [Abstract][Full Text] [Related]
11. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence studies for immunoglobulins and complement C3 in synovial joint membranes in psoriatic arthritis.
Fyrand O; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 Sep; 29(3):422-7. PubMed ID: 338220
[TBL] [Abstract][Full Text] [Related]
13. Complement biosynthesis in human synovial tissue.
Moffat GJ; Lappin D; Birnie GD; Whaley K
Clin Exp Immunol; 1989 Oct; 78(1):54-60. PubMed ID: 2805423
[TBL] [Abstract][Full Text] [Related]
14. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
Kokkola R; Sundberg E; Ulfgren AK; Palmblad K; Li J; Wang H; Ulloa L; Yang H; Yan XJ; Furie R; Chiorazzi N; Tracey KJ; Andersson U; Harris HE
Arthritis Rheum; 2002 Oct; 46(10):2598-603. PubMed ID: 12384917
[TBL] [Abstract][Full Text] [Related]
15. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
Schäfer H; Mathey D; Hugo F; Bhakdi S
J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
[TBL] [Abstract][Full Text] [Related]
16. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
Emmrich J; Geiler G
Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis.
Ziegler B; Gay RE; Huang GQ; Fassbender HG; Gay S
Am J Pathol; 1989 Jul; 135(1):1-5. PubMed ID: 2774054
[TBL] [Abstract][Full Text] [Related]
18. [Monocytes/macrophages in synovial tissue in chronic polyarthritis and arthrosis--differentiating from monoclonal antibodies].
Wörth WD; Müller W; Oberholzer M
Z Rheumatol; 1987; 46(3):101-11. PubMed ID: 3498275
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the complement split product C3dg in synovial fluid as a possible diagnostic guide in inflammatory arthropathies.
Michel BA; Schlumpf U; Simmler F
J Rheumatol; 1989 Sep; 16(9):1201-4. PubMed ID: 2810276
[TBL] [Abstract][Full Text] [Related]
20. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
